Lung cancer in smoking patients inversely alters Fpg and endonuclease III human homologues

I. Horváth, S. Goto, H. Nakamoto, K. Udud, Z. Pápai, Z. Radák (Budapest, Hungary; Funabashi, Japan)

Source: Annual Congress 2002 - Thoracic oncology: biology
Session: Thoracic oncology: biology
Session type: Poster Discussion
Number: 1498
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Horváth, S. Goto, H. Nakamoto, K. Udud, Z. Pápai, Z. Radák (Budapest, Hungary; Funabashi, Japan). Lung cancer in smoking patients inversely alters Fpg and endonuclease III human homologues. Eur Respir J 2002; 20: Suppl. 38, 1498

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
DNA methylation is associated with lung function levels in never-smokers
Source: International Congress 2017 – Epigenetics of lung function
Year: 2017



Expression of peroxiredoxin I, III and thioredoxin in human lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 102s
Year: 2005

Polymorphisms associated with lung cancer are closely related to COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 136s
Year: 2007

Gender differences in the expression of double strand break genes in early non-small lung cancer (NSCLC) patients
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009

DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013


DNA methylation mediates the association between occupational exposures and lung function
Source: International Congress 2017 – Epigenetics of lung function
Year: 2017



Research occurrence of N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 antigens in the circulating immune complexes, isolated from serum of patients with lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016


Methylation, smoking, and reduced lung function
Source: Eur Respir J, 54 (1) 1900920; 10.1183/13993003.00920-2019
Year: 2019



A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Association of DNA repair gene XRCC7 G6721T polymorphisms withnon-small cell Lung cancer
Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep
Year: 2019


MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

DNA damage in lymphocytes from COPD patients with and without lung cancer
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017

Elevated endogenous thrombin potential in patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003

A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Genetic polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Role of genome integrity genes polymorphism in risk of lung cancer of middle-aged men
Source: Eur Respir J 2007; 30: Suppl. 51, 132s
Year: 2007

Polymorphisms in telomere maintenance genes and risk of lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC)
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020

Type XIX collagen quantified in serum targeting the anti-tumorigenic NC1 domain is elevated in early and late stage lung carcinoma patients and COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020